Showing results (121-130 of 302) with videos related to
Sort By:
Pageof 31
American Journal of Clinical Oncology|March 1, 2014
The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With RadiationJonathan D Schoenfeld, Jennifer Y Wo, Harvey J Mamon, et al.Cancer Chemotherapy and Pharmacology|February 4, 2023
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.The American Journal of Surgical Pathology|March 27, 2018
Histologic and Outcome Study Supports Reclassifying Appendiceal Goblet Cell Carcinoids as Goblet Cell Adenocarcinomas, and Grading and Staging Similarly to Colonic AdenocarcinomasMasato Yozu, Melanie E Johncilla, Amitabh Srivastava, et al.The Oncologist|November 22, 2017
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I ResultsEileen M O'Reilly, James Roach, Paul Miller, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 6, 2020
Functional Impairment, Symptom Burden, and Clinical Outcomes Among Hospitalized Patients With Advanced CancerDaniel E Lage, Areej El-Jawahri, Charn-Xin Fuh, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 30, 2020
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal AdenocarcinomaChunxia Du, Annacarolina da Silva, Vicente Morales-Oyarvide, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumorsDavid P Ryan, Joseph P Eder, Thomas Puchlaski, et al.Investigational New Drugs|January 24, 2004
A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignanciesJoseph P Eder, Rocio Garcia-Carbonero, Jeffrey W Clark, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 19, 2005
Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinationsJennifer F Tseng, Christopher G Willett, Carlos Fernandez-del Castillo, et al.Annals of Surgery|January 15, 2005
Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancerChristopher G Willett, Carlos Fernandez Del Castillo, Helen A Shih, et al.Pageof 31